Medical Products Supply Chain Weekly Review – September 2021 # 3 | Alston & Bird
Last week, the White House COVID-19 response team indicated that the administration was ready to begin providing booster doses to eligible Americans. The FDA has alerted clinical lab staff and healthcare professionals to false negatives with certain SARS-CoV-2 molecular tests. Please see details of this and other supply chain developmentsRead More →